Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01910753
Other study ID # I12018 APANVADS
Secondary ID
Status Terminated
Phase N/A
First received July 22, 2013
Last updated September 6, 2016
Start date May 2013
Est. completion date June 2015

Study information

Verified date September 2016
Source University Hospital, Limoges
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the feasibility of resistance training and physical functioning associated with nutrition therapeutic education in head and neck cancer patients, during their treatment (chemotherapy with or without radiotherapy).


Description:

The loss of muscle mass (i.e., sarcopenia) has been identified as a negative prognosis descriptor, disregarding the type of cancer. It is also a predictive descriptor for treatment-related toxicity. Therefore it appears crucial to save muscle mass of patients, following an adequate physical training together with a personalised diet program. The latter point is of major importance as malnutrition concerns 45% patients having head and neck cancer cancer, who stop physical activity due to extreme tiredness and decrease of quality of life. In the present project, we plan a physical activity program that would be adapted to each patient, accompanied by the rethought diet over a 3-month period. The adapted physical activity (APA) is constituted of two aerobic stages and one resistance training stage per a week. The evaluation will then proceed at three different moments, namely (i) at T0 i.e., beginning of the program, (ii) at 3 months i.e., when the program will be stopped, and (iii) at 6 months i.e., three months after the program stop. This evaluation will include the success rate, the level of satisfaction, the physiological parameters (VO2max, muscle mass and strength, BMI) and quality of life.


Recruitment information / eligibility

Status Terminated
Enrollment 10
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age>18 years

- Written informed consent provided before any study specific procedures

- Consent to cooperate for clinical assessments

- Affiliation to a social security regime or beneficiary of equivalent social protection

- Performance status between 0 and 2

- Squamous cell carcinoma of oral cavity, oropharynx or hypopharynx

- Stage III - IV (T1-T4, N0-N3, M)(UICC 2002)

- Indication of radiotherapy and chemotherapy post-operative or first-line metastatic chemotherapy or in inoperable condition

- Ability to understand the nature, goal and study methodology

Exclusion Criteria:

- Prior neoadjuvant chemotherapy

- timed vital capacity< 70%

- Presence of another severe pathology including:

- severe or chronic cardiac, pulmonary, renal and/or hepatic insufficiencies

- Cons-indication to physical activity practice, at discretion of the investigator

- Patient under guardianship

- Psychological, social, geographical, or familial reasons prohibiting physical activity and follow-up

- Any other primary tumor during the last 5 years

- Pregnant or nursing

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
APA
A 3-month program for physical activity and diet education will be followed. An exercise specialist will supervise patients twice per week, during the first six weeks. They will also follow nutrition counselling and therapeutic education by a dietician once per week. During the last six weeks, they will just follow a guide for safe and appropriate exercise regimen. The dietician will call patient weekly during this final period.

Locations

Country Name City State
France CHU LIMOGES - Explorations Fonctionnelles Respiratoires Limoges
France CHU LIMOGES - Oncologie Limoges

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary feasibility of the APA with a composite outcome measure The evaluation criteria for the PA program will be:
The success rate that will be reached if 80% of physical exercises will be performed by the patient, over the 3-month period,
The level of satisfaction that will be evaluated with questionnaires filled by the patient.
3 months No
Secondary Evaluation of the personalised diet program and the therapeutic education with a composite outcome measure. The evaluation criteria for the personalised diet program and the therapeutic education will be:
The success rate that will be reached if 80% of requirements will be addressed by the patient,
The level of satisfaction that will be evaluated with questionnaires filled by the patient.
3 months No
See also
  Status Clinical Trial Phase
Completed NCT05746780 - Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
Recruiting NCT04708470 - A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers Phase 1/Phase 2
Completed NCT00318890 - Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck Phase 1/Phase 2
Completed NCT00798655 - Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer Phase 2
Completed NCT06010381 - Muscle Energy Technique Versus Maitland Mobilization on Shoulder Pain and Disability N/A
Recruiting NCT06432998 - Perineal Massage in Women With Gynecological Cancer N/A
Completed NCT02714920 - DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD) N/A
Completed NCT01194466 - Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC) N/A
Recruiting NCT03530033 - Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring N/A
Recruiting NCT05549414 - Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System N/A
Recruiting NCT04750434 - PET MRI as a Staging Tool for Head and Neck Cancer
Withdrawn NCT05472506 - Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer Phase 1
Not yet recruiting NCT04261179 - Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer Phase 4
Completed NCT00723463 - Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue Phase 0
Recruiting NCT04673981 - Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA) N/A
Not yet recruiting NCT05946577 - Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study
Completed NCT05246891 - Rehabilitation Nursing Program in Otolaryngology
Completed NCT02738268 - Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients N/A
Recruiting NCT04722523 - A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer Phase 1
Completed NCT03245788 - Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study N/A